In 2023, Intra-Cellular Therapies conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2023, Intra-Cellular Therapies generated a total of 2 metric tonnes of waste.
Of this amount, 20% of Intra-Cellular Therapies's total waste generated was recovered through methods such as recycling, reuse, or composting, while 80% was disposed of through landfilling, incineration, or combustion.
In 2023, Intra-Cellular Therapies reported a total waste generation of 2 metric tonnes, of which 20% was recovered through recycling, reuse, or composting. This low recovery rate highlights limited waste diversion and suggests that Intra-Cellular Therapies may be relying more heavily on landfill or incineration, underscoring opportunities for stronger resource recovery initiatives.
In 2023, Intra-Cellular Therapies generated a total of 2 metric tonnes of waste.
Of this amount, 80% of Intra-Cellular Therapies's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 20% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.